Results 21 to 30 of about 21,508 (259)

Successful therapeutic plasma exchange in cold autoimmune hemolytic anemia in patient with disseminated tuberculosis

Reumatismo, 2021
An association of autoimmune hemolytic anemia with disseminated tuberculosis is an exceedingly rare entity. We describe herein a case of cold hemolytic autoimmune anemia associated with miliary tuberculosis resolved with blood transfusions, therapeutic ...
N. Belfeki, A. Strazzulla, P. Isnard, S. Hamrouni, B. Maamar, P. Soulier, M. Monchi, S. Diamantis   +7 more
doaj   +1 more source

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?

Hematology Reports, 2018
Vascular events are the most common clinical complication of essential thrombocythemia, leading to sign and symptoms of this disease. There are various sign and symptoms of essential thrombocythemia, such as thrombosis in artery or vein, and enlarged ...
Nata Pratama Hardjo Lugito, Andree Kurniawan, Yohanes Chandra Kurniawan, Enny Yacobus, Edwin Halim   +4 more
doaj   +1 more source

Cold Agglutinin-induced Hemolytic Anemia as the Primary Presentation in Systematic Lupus Erythematosus (SLE) in Pregnancy Triggered by Infection: A Case Report

Case Reports in Clinical Practice, 2022
Autoimmune hemolytic anemia (AIHA) may be the first manifestation of systematic lupus erythematosus (SLE). Antierythrocyte antibodies in SLE are mainly warm-type Immunoglobulin G (IgG), but mixed-type AIHA is also reported.
Vajihe Marsusi, Ashraf Sadat Jamal, Laleh Eslamian, Maasoumeh Saleh, Behnaz Nouri, Danial Dehghan   +5 more
doaj  

Hemolytic Anemias: Autoimmune and Beyond

Journal of the Advanced Practitioner in Oncology, 2021
During JADPRO Live Virtual 2020, Ravi Krishnadasan, MD, FACP, provided an overview of the terminology of hemolysis, laboratory tests used in the diagnosis of hemolytic anemias, and appropriate indications for treatment of the various hemolytic anemias.
openaire   +3 more sources

Autoimmune Hemolytic Anemia Caused by Cold Agglutinin Antibodies in Systemic Lupus erythematosus—a Rare Association: Case Report

, 2023
Luis Miguel Osorio-Toro,1– 3 Jhon Herney Quintana-Ospina,1– 3 Luis Álvaro Melo-Burbano,1– 3 Paola Andrea Ruiz-Jiménez,1– 3 Jorge Enrique Daza-Arana,1,4 Giovanna Patricia Rivas-Tafurt,1,2 Jorge Hernán Izquierdo-Loaiza1,2 1Specialization in Internal ...
Ruiz-Jiménez PA, Rivas-Tafurt GP, Quintana-Ospina JH, Osorio-Toro LM, Daza-Arana JE, Izquierdo-Loaiza JH, Melo-Burbano LÁ   +6 more
core  

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia

, 2020
Autoimmune hemolytic anemia is a rare condition characterized by destruction of red blood cells with and without involvement of complement. It is associated with significant morbidity and mortality.
Irina Murakhovskaya
core   +1 more source

Vitamin B12 and vitamin D deficiencies: An unusual cause of fever, severe hemolytic anemia and thrombocytopenia

Journal of Family Medicine and Primary Care, 2015
The array of diagnostic workup for pyrexia of unknown origin (PUO) generally revolves in searching for infections, inflammatory/autoimmune, and endocrine etiologies.
Vikas A Mishra, Rishit Harbada, Akhilesh Sharma   +2 more
doaj   +1 more source

Severe refractory autoimmune hemolytic anemia with both warm and cold autoantibodies that responded completely to a single cycle of rituximab: a case report

Journal of Medical Case Reports, 2011
Introduction Mixed warm and cold autoimmune hemolytic anemia runs a chronic course with severe intermittent exacerbations. Therapeutic options for the treatment of hemolysis associated with autoimmune hemolytic anemia are limited.
Forte Frank, Gottesman Aaron, Varma Seema, Nakhl Fadi, Szerszen Anita, Gupta Shilpi, Dhar Meekoo   +6 more
doaj   +1 more source

Development of New Drugs for Autoimmune Hemolytic Anemia

Pharmaceutics, 2022
Autoimmune hemolytic anemia (AIHA) is a rare disorder characterized by the autoantibody-mediated destruction of red blood cells, and treatments for it still remain challenging.
Zhengrui Xiao, Irina Murakhovskaya
doaj   +1 more source

Canine autoimmune hemolytic anemia: management challenges.

, 2016
Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial.
Skelly BJ, Swann JW
core   +1 more source